|12th October 2020||Stuart M. Grant||50,000||Open or private purchase||$3.60||$180,000.00|
|12th October 2020||Stuart M. Grant||50,000||Open or private purchase||$3.50||$175,000.00|
|24th September 2020||Stuart M. Grant||25,000||Open or private purchase||$2.98||$74,500.00|
|24th September 2020||Stuart M. Grant||50,000||Open or private purchase||$3.00||$150,000.00|
|18th September 2020||Jennifer G Clasby||26,737||Exercise of derivative||$1.95||$52,137.15|
|11th September 2020||Anthony Y Sun||7,288||Grant/award etc.||$0.00|
|11th September 2020||Charles E Iv Mather||7,288||Grant/award etc.||$0.00|
|11th September 2020||Fredric N Eshelman||7,288||Grant/award etc.||$0.00|
|11th September 2020||Kenneth B Jr Lee||7,288||Grant/award etc.||$0.00|
|11th September 2020||Ernest Mario||7,288||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Edenovia, Inc. engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine.